Mike Tyson joins the checklist of celebrities launching a hashish line

In this handout picture, Mike Tyson attends the Hublot x WBC “Night of Champions” gala at the Encore Hotel on May 03, 2019 in Las Vegas, Nevada.

Omar Vega | HUBLOT via Getty Images

Mike Tyson told CNBC that cannabis makes him “a different person” and that he is releasing his Tyson 2.0 cannabis line to help others who are looking for emotional and physical relief.

“It’s really all about the love of medicine,” said the co-founder and chief brand officer of Tyson 2.0. “I put a lot of time into farming and discovered the right strain.”

The former heavyweight boxing champion added, “It’s gotten pretty complex, but the best time of my life.”

Tyson 2.0 launched in Colorado on Friday through a partnership with Columbia Care, a US-based multi-state operator that currently operates 99 pharmacies in 16 states, according to its website.

“Based on Mike Tyson’s passion for cannabis and the insights he brought to the brand through his own positive results, we knew we needed to get this line of products to market as quickly as possible, which has as broad an appeal as we can are thrilled to be able to intensify our partnership at this point in time, “said Jesse Channon, Columbia Care’s Chief Growth Officer, in a statement. using our experience and size to bring them to fruition across the country. “

Zoom In Icon Arrows pointing outwards

The Tyson 2.0 brand will begin selling 1 ounce flower pouches of a variety of varieties – including the popular “Maui Wowie” – of varying potency at a price of $ 89.95. The average price for an ounce of cannabis in the US in November is $ 82, according to data from Cannabis Benchmarks. Tyson 2.0 plans to sell pre-rolls and 3.5-gram flower jars in the coming months.

“He doesn’t just write his name on a product. We won’t bring any product to market unless Mike agrees, ”Adam Wilks, CEO of Tyson 2.0, told CNBC. Tyson is involved in the research and development process, added Wilks. “Mike can actually choose the strains he prefers, with ‘Sour Diesel’ and ‘The Toad’ being some of his favorites,” he said.

“My best strain is ‘Sour Diesel,'” Tyson said with a smile as he explained his goal of building new and deeper relationships with his fans through cannabis. “It’s a strong bond with the buyer,” he said.

The boxing legend joins a long list of celebrities who have used her fame to promote lines of cannabis or CBD.

The family of music legend and cannabis advocate Bob Marley has the “Marley Nature” Cannabis line in 2016. Rapper and mogul Jay-Z got the “Monogram” Cannabis line in 2020. Actor and comedian Seth Rogen, best known for stoner comedies, started his “Houseplant” Cannabis companies in 2019. Martha Stewart launched her eponymous CBD Brand in 2020 and markets the wellness product line for humans and animals.

Tyson, 55, said he also uses his line of cannabis for wellness, noting, “I use them for life.”

“If I don’t use it for a week or three days, some of that ability, I’m a completely different person. And I’m not a personable person,” he said.

The perfect hashish play is Revolutionary Industrial Properties

Poshmark: “You missed the quarter badly tonight, and it’s interesting because everyone else in this industry seems to be doing pretty well, so that’s what I call disappointing.”

Tandem diabetes care: “They are doing very well and I give you two things: I like Tandem Diabetes Care and I continue to support Dexcom. I think they are doing amazingly well.”

Innovative industrial real estate: “Everyone, if they try to get me to recommend Tilray or Canopy growth or anyone, I always come back and say the same thing. They are innovative industrial properties. Ben Stoto, my research director, and I keep talking about how this is the only one you can buy. One and only. Let’s stop thinking about it. ”

Big 5 sport: “They knocked the ball out of the park, and I’ll give you a two as well. … [Dick’s Sporting Goods] is fine too. Both are fine. Sporting goods didn’t stop as the pandemic subsided. We discovered nature and like it. “

Nokia: “I like Nokia. They’re making a comeback. Cheer up, Nokia is fine. I think you might have a winner.”

Vale SA: “No. We don’t buy iron ore. We think it’s late in the cycle.

Julio Jones sued by hashish firm alleging fraud, cash laundering

Tennessee Titans wide receiver Julio Jones is being sued by a cannabis company in connection with alleged fraud and money laundering, according to court documents The Tennessean received late Tuesday night.

Genetixs, a California-based cannabis company, filed a lawsuit in the Los Angeles County Superior Court on July 21, which named Jones, his former Atlanta Falcons teammate, Roddy White, and White’s firm, SLW Holdings, among the defendants. SLW Holdings is one of the five members of Genetixs.

The lawsuit alleges that the defendants illegally administered and operated the Genetixs facility and have not reported any cannabis sales since March 2021. Genetixs estimates that about $ 3 million a month in cannabis has been harvested and illegally sold since then.

Jones and White, who were teammates with the Falcons from 2011 to 2015, are accused of working with a man named John Van Beek and his son Shaun Van Beek to run a black market cannabis operation through the Genetixs facility. Jones and White had invested in Genetixs, according to the documents through White’s SLW Holdings.

John Van Beek was hired by Genetixs in March 2020 as the on-site manager and operator of its rented facility in Desert Hot Springs, California. He is accused of breach of contract, failure to report cannabis sales and failure to provide the company with budgets, bills, expenses and other paperwork, according to the lawsuit.

A government inspection of the facility found numerous violations and John Van Beek was fired in March 2021.

The Van Beeks allegedly disabled cameras in the facility while it was in operation and at some point prevented a new manager from entering, the complaint said.

Without the consent of Genetixs, the defendants are accused of having given up the facility and handed over the premises to the landlord. They “stole, removed and abused Genetixs cannabis” from 22 crops and allegedly damaged machinery, equipment and other valuables, property valued at millions of dollars, the documents said.

Among others, Jones, White, the Van Beeks and other defendants are sued:

  • Conspiracy to cheat
  • Change
  • Violation of the duty of loyalty
  • Aid to breach of duty of loyalty and fraud
  • Violation of the member’s duty of good faith
  • Unjustified enrichment
  • accounting
  • Exemption from assessment
  • Civil conspiracy to commit fraud
  • Injunctive relief

Genetixs calls for general, criminal and exemplary claims for damages and injunctive relief.

The Titans were not immediately available for comment late Tuesday night.

The Titans acquired Jones in a deal with the Falcons last month, a move that gives Tennessee a dynamic offensive on paper for 2021. 32-year-old Jones, a two-time all-pro selection of the first team and seven-time professional bowler, established himself with the Falcons (2011-20) as one of the best wide receivers of his generation in a decade.

Jones was number 6 overall in Atlanta in 2011.

Ben Arthur reports on the Tennessee Titans for the USA TODAY Network. Contact him at barthur@gannett.com and follow him on Twitter at @benyarthur.

Bophelo Bioscience Grows Premium DNA Genetics California-Fashion Hashish in Lesotho with GACP on the Approach

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

All figures in USD, unless stated otherwise

TORONTO, May 21, 2021 /CNW/ – Halo Collective Inc.’s (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN) wholly-owned subsidiary Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”) is partnering with OG DNA Genetics Inc. (“DNA Genetics” or “DNA”) to grow premium California-style cannabis in Lesotho. Bopehlo operates a 200-hectare cannabis cultivation site near Mafeteng, the first Special Economic Zone (“SEZ”) in Lesotho, Africa.1 DNA Genetics is one of the world’s leading creators of high-quality cannabis seeds, whose strains consistently contain high cannabinoid and terpene concentrations. Bophelo and DNA entered a seed purchase agreement giving Bophelo exclusive rights to develop new and existing strains of DNA medical cannabis in Lesotho for export worldwide.

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Bophelo Bioscience Grows Premium DNA Genetics California-Style Cannabis in Lesotho (CNW Group/Halo Collective Inc.)

Harvest Update

Bophelo finalized the summer harvest with more than 400,000 grams of sellable flower. Despite difficult growing conditions this season due to eight weeks of unusual weather, strong results were achieved with eight strains providing over 20% of THC A in line with the highest quality sun-grown cannabis found in Oregon and California.

Current test results from ISO laboratory testing are shown below:

Strain Name

THC A%

OG DNA Holy Grail (1)

28.2

Blue Berry Haze

23.2

Mother Load Kush

22.9

OG DNA Chocolope (1)

22.7

Sugar Punch

21.9

Kolossus

21.0

Afghani Fields

20.7

Madchem

20.2

This marks a significant milestone in quality, as 20% and higher is the desired standard in most medical markets. Strains above 25% are considered the highest quality for natural sun-grown cannabis. Additional strains await test results with the anticipation that more strains that will test over 20%. Each of these strains has been selected as a “Production Strain” and will be a large section of our spring planting beginning in October.

Story continues

The success of the DNA strains in the Lesotho environment has yielded high quality cannabis that would be expected to sell at a premium price. The DNA Genetics team plans to visit Bophelo’s cultivation site in late June or early July to establish more unique strains potentially by crossing local genetics to make a new class of African-California cannabis strains as part of the Halo and Bophelo partnership.

Aaron Yarkoni, Co-Founder of DNA Genetics said, “We’re excited about all the progress we have made in Africa with Halo. We have grown all over the world, and this is the first time I have seen both the Prime Minister with his cabinet visit the site. It’s an honor to participate in creating a Special Economic Zone, creating jobs, and most of all, providing our highest quality cannabis strain varieties to people all over the world. The team in Lesotho has been doing an incredible job with our genetics, and we’re proud to show the world what we’ve achieved. It’s been a great partnership.”

Image captured at Bophelo Bioscience of the recent visit of The Prime Minister with his Cabinet Members (CNW Group/Halo Collective Inc.)

Image captured at Bophelo Bioscience of the recent visit of The Prime Minister with his Cabinet Members (CNW Group/Halo Collective Inc.)

“The cannabis we are growing would be top-shelf sun-grown cannabis. Our cost of production is among the lowest in the world, and our quality is among the highest, as independent lab test results demonstrate. I am excited to scale this year and then next and start bringing strong revenue with high margins with the cannabis that all medicinal cannabis patients will demand,” said Kiran Sidhu, CEO and Co-Founder of Halo.

Sales Opportunities

Bophelo continues to work on the export process in Lesotho and the import process in South Africa to allow independent third-party compliance product testing. The result will enable Bophelo to sell products abroad through third parties exporters and resellers.

Interested third parties have been identified, and Bophelo expects to make initial sample product sales abroad as soon as the protocols are firmly established. It is anticipated that these protocols will be completed by late July.

GACP Certification Targeted for June

With the outer 1.6 km of fence complete, work is now beginning on the inner fence. These two elements significantly increase the security of the site—a significant accomplishment. (CNW Group/Halo Collective Inc.)

With the outer 1.6 km of fence complete, work is now beginning on the inner fence. These two elements significantly increase the security of the site—a significant accomplishment. (CNW Group/Halo Collective Inc.)

With the outer 1.6 km of fence complete, work is now beginning on the inner fence. These two elements significantly increase the security of the site—a significant accomplishment. The inner fence should be completed by June. The ablutions continue to progress with the roof to be installed and inner finish work expected to be completed within four weeks. Proper curing, storage, and post-harvest processing facilities are the longest lead time items and can possibly be done in late June. The state-of-the-art security system and corporate headquarters are already finished.

Cravo Green Houses Starting to Arrive

Work has been completed to supply electricity sufficient to power 1 acre (0.4 hectares) of greenhouse space—a major accomplishment. Planning is in process to build out the electrical infrastructure in preparation to start foundation work, which is expected to be completed by the middle of July. Bophelo plans to use high-quality systems, including EPHOS® lighting systems.

Despite numerous delays due primarily to Covid-19, the first container of Cravo parts is expected to be on time and arrive in South Africa by the end of June. This shipment contains the foundation for the greenhouse. Plans to build out the drainage and foundation are being finalized with the expectation to pour concrete starting in late July and early August. The goal is to begin planting in this first greenhouse by October. Once this prototype proves successful, Bophelo plans to implement a total of 15 acres of Cravo Greenhouses by the middle of 2023, capable of producing up to 48 million grams of flower annually, which is expected to be one of the largest greenhouse complexes in the world.

Extraction Will Soon Be Up and Running

The 16 m2 extraction facility is almost complete, with initial extractions expected to begin in June. The first month of extraction will be focused on learning standard operating procedures to ensure safe extractions. Bophelo will utilize the “B” buds from its cultivation along with cannabis procured from other license holders. Shatter and oil will be produced for sale within Africa to additional medical licenses. If possible, the oil will be exported out of Africa as well.

Covid-19 Mitigation Strategy in Place

Management at Bophelo anticipated the possibility of a third wave of Covid-19 and prepared a contingency grow plan to allow the expansion of an additional two acres (0.8 hectares) of grow space. This would increase Bophelo’s conventional greenhouse space at a minimum from 0.7 acres (0.3 hectares) to 2.7 acres (1.1 hectares) even in the event of a total lockdown due to Covid-19. This canopy would be in addition to the planned Cravo Greenhouses. Bophelo expects to have at least 6 acres of canopy growing by May 2022, as much as Halo’s East Evan’s Creek Facility with equal or better quality but at a significantly lower cost and contributing to Halo’s gross margin .

“Covid had a significant impact on Bophelo’s ability to expand in 2021. We built the team and grew despite the challenges as well as learned some valuable lessons. We are a few weeks late on GACP certification but aim to be certified in July. We are well-positioned to continue growing and thriving at a fast pace,” said Andreas Met, Managing Director of Bophelo and Halo Co-Founder.

About Halo Collective Inc.

Halo is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes quality cannabis flower, oils, and concentrates and has sold approximately nine million grams of oils and concentrates since inception. Halo continues to evolve its business and scale efficiently, partnering with trustworthy leaders in the industry, who value the Company’s operational expertise in bringing top-tier products to market. Current growth includes expansion in key U.S. markets, the United Kingdom and Africa, with planned expansion into the Canadian retail market.
Halo is led by a strong, diverse, and innovative management team with deep industry knowledge and blue-chip experience. The Company is currently operating in the United States in California and Oregon. The Company sells cannabis products principally to dispensaries under its brands, Hush, Mojave, and Exhale, and under partnership or license with OG DNA Genetics, Terphogz and FlowerShop*, a cannabis lifestyle and conceptual wellness brand in which G-Eazy is a partner and key member of FlowerShop*.

As part of continued expansion and vertical integration in the U.S., Halo boasts several grow operations throughout Oregon and California. In Oregon, the Company has a combined 9 acres of outdoor cultivation, including East Evans Creek, a six-acre grow site in Jackson County, Blue Sky Farms, a two-acre grow site located in Jackson County and Winberry Farms, a one-acre grow site located 30 miles outside Eugene in Lane County. In California, the Company is building out Ukiah Ventures, a planned 30,000-square-foot indoor grow and cannabis processing facility, including up to an additional five acres of industrial land to expand this indoor grow site. Recently, Halo partnered with Green Matter Holding to purchase Bar X Farm in Lake County, developing up to 80 acres of cultivation which would comprise the largest grow in California.

Internationally, the Company’s subsidiary Bophelo is currently cultivating medicinal cannabis in Lesotho. Once fully built out, Halo believes Bophelo to be one of the largest licensed marijuana cultivation sites in the world with a future capacity of up to 495 acres. To further Halo’s global presence, the Company has recently acquired CBPM importation and distribution licensing in the United Kingdom via medical cannabis suppliers Canmart. Halo expects the cultivation and manufacturing operations of Bophelo, combined with the importation and distribution capabilities of Canmart, to drive a well-positioned business to serve the U.K. market.

The Company also has acquired a range of software development assets, including technology platforms CannPOS, Cannalift, and, more recently, CannaFeels. Halo also owns the discrete sublingual dosing technology, Accudab. The Company intends to spin-off these assets along with its intellectual property and patent applications into its subsidiary Halo Tek Inc. and complete a distribution to shareholders on a record date to be determined by Halo.

For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com

Connect with Halo Collective: Email | Website | LinkedIn | Twitter | Instagram

About OG DNA Genetics Inc.

DNA was rooted in Los Angeles and founded in Amsterdam in 2004 by Don Morris and Aaron Yarkoni. Over the last decade, the Company has built and curated a seasoned genetic library and developed proven standard operating procedures for genetic selection, breeding, and cultivation. In a world that is increasingly opening up to commercial cannabis activity, DNA is positioned to become the first, truly geographically diversified company with multiple partnerships with top-licensed producers and brands that have built their companies and global presence utilizing the “Powered by DNA” model.

For more information, please visit www.dnagenetics.com

About Bophelo

Bophelo is based in the Kingdom of Lesotho, Southern Africa, and is the holder of one of a limited number of licenses issued in Lesotho for the production of medicinal cannabis products. Situated 70 kilometers from the capital city of Maseru, Bophelo’s operating site is an ideal location with ample labor, free water, flat land area, and low crime rates. The favorable high altitude and low humidity climate provide clean and organic growing conditions within the mountainous region. With the motto “Sechaba se tlisa lerou” translated in English, meaning community brings wealth, Bophelo highlights the value of community and empowerment of the Basotho people, focusing on the development of women and youth. Bophelo is an indirect, wholly owned subsidiary of Halo.

For more information about Bophelo, please visit www.bophelo-bioscience.com

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or may contain statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information may relate to anticipated events or results including, but not limited to the development and expansion of Bophelo’s operations and the granting of certifications, Bophelo’s prospects, including with respect to the distribution of cannabis products produced by Bophelo, Halo’s planned expansion into the Canadian retail market, the expected size and capabilities of the final facility planned at Ukiah Ventures, the size of Halo’s planned cultivation facility in Northern California and the ability of Bophelo and Canmart to serve the E.U., U.K. and Australian market.

By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: unforeseen delays or circumstances that prevent the applicable stock exchanges from commencing trading in the Company’s shares or warrants; delays in obtaining required licenses or approvals, delays or unforeseen costs incurred in connection with construction, the ability of competitors to scale operations in Northern California, delays or unforeseen difficulties in connection with the cultivation and harvest of Halo’s raw material, changes in general economic, business and political conditions, including changes in the financial markets; and the other risks disclosed in the Company’s annual information form dated March 31, 2021 and other disclosure documents available on the Company’s profile at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.

www.haloco.com (CNW Group/Halo Collective Inc.)

www.haloco.com (CNW Group/Halo Collective Inc.)

SOURCE Halo Collective Inc.

Cision

Cision

View original content to download multimedia: https://www.newswire.ca/en/releases/archive/May2021/21/c9538.html

Ethical Hazard and the Way forward for Cash | Midas Letter RAW ft Emerald Heath & Hashish Fund Supervisor

Money is an economic unit that acts as an offer of exchange for transaction purposes in an economy. But what happens to this concept if the US Treasury Department’s 10-year rate is different from the current Fed rate? Are stimulus checks and capital generation enough to suppress returns? Is hyperinflation here yet? Are cryptocurrency and bitcoin (BTC) valuations showing that confidence in central banks is deteriorating to keep the inflationary boogie man under wraps? Stay tuned as we talk about the moral hazard in “money” today and the future of money.

Midas Letter RAW is the disrespectful / intelligent investing show for the little guy. A former stockbroker and Reformed accountant, Ed Milewski, brings his knowledgeable but unconventional technical chart observations into focus. At the same time, investment author James West criticizes the machinations, gimmicks and listings that are being forced upon private investors by what we call capital markets institutions.

In today’s episode we have two exclusive interviews on deck:

1. Emerald Health Pharmaceuticals [not to be confused with Emerald Health Therapeutics Inc (CVE:EMH) (OTCMKTS:EMHTF) (FRA:TBD) – although both are owned by Emerald Health Sciences.] – a science-based company that leverages the unique convergence of science, biology and cannabis molecules like cannabidiol (CBD) and cannabigerol (CBG) to create new molecules – that can produce beneficial effects (which CBD does not produce) to do so possibly treat – far incurable diseases.

Emerald is currently running an increase in Regulation A (ending at midnight on Sunday March 28, 2021) that will allow individuals to invest in the private company. See here to see how the CEO explains it.

2. Charles Taerk, CEO of Faircourt Asset Management and Manager of the Ninepoint Alternative Health Fund – a manager who has his finger on the pulse of cannabis investing (evidenced by the excellent financial performance of his funds). He makes a strong case for why US cannabis multi-state operators (MSO) have a significant advantage over Canadian licensed producers (LP). We could no longer agree with his thesis, and we believe this interview will give our weed audience a lot of thought-provoking.



Disclosure

Midas Letter serves only as a source of information and is in no way to be understood as investment advice. James West, the author and editor of the Midas Letter, has no authority to advise investors and is only making this information available to readers who want to know what he invests in and how he makes such decisions.

Investing in emerging public companies involves high risk and investors in such companies could lose all of their money. Always consult a properly accredited investment professional in your jurisdiction before making any investment decision.

Midas Letter occasionally accepts advertising and sponsorship fees from public companies featured on this website. James West and / or Midas Letter may also receive compensation from companies affiliated with companies featured on this website. James West and / or Midas Letter also invest in companies on this website. Therefore, readers should consider any information on this website to be biased.